Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New muscle measurement method tested in seniors

NCT ID NCT02062086

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new technique that uses a special form of creatine (deuterated creatine) to measure muscle mass more directly and accurately in older adults. The goal was to see if this method works well in both healthy older adults and those recovering from a hip fracture. The study was stopped early, but it aimed to improve how we track muscle loss in aging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

33 people

The number who actually took part.

Started

Jun 2014

Finished

Dec 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria Population 1: Community-dwelling older adults: * Community-dwelling at the time of the assessment * Ambulatory without human assistance at the time of the assessment * ADL (activity of daily living)equal to 5 or more at the time of the assessment Population 2: Older adults recovering after hip fracture surgery: * Age ≥ 65 at the time of the fracture * Minimal trauma hip fracture (Diagnosis of closed fracture of the proximal femur and no history of a fall from height higher than standing height (e.g. fall from a roof or a ladder); no history of a high impact fracture (e.g. car accident, skiing) * Unilateral hip fracture * Surgical repair of hip fracture * Surgical intervention taking place within 7 days since admission to the acute care unit. * Living in the community at the time of the fracture * Anticipated discharge back to the community * Ambulatory without human assistance prior to the fracture * ADL (activity of daily living) equal to 5 or more prior to the fracture Exclusion criteria Population 1:Community-dwelling elderly: * Diagnosis of dementia * Presence of cognitive impairment (assessed during clinical follow-up using standardized cognitive tools such as MMSE (Mini Mental Status Examination) or MOCA (Montreal Cognitive Assessment), during pre-screening period). * Inability to provide informed consent * Presence of severe or uncontrolled neurodegenerative disease like Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis * Presence of an underlying muscle disease other than age-associated muscle waste or disuse atrophy. * History of stroke with residual hemiplegia * Diagnosis of a severe medical or psychiatric condition making the participant unlikely to understand or comply with study protocol. * Diagnosis of malignancy done in the 18 months prior the baseline visit. * Severe renal failure Population 2: Older adults recovering from hip fracture: * Pathological hip fracture * Diagnosis of dementia * Presence of cognitive impairment (assessed during clinical follow-up using standardized cognitive tools such as MMSE (Mini Mental Status Examination) or MOCA (Montreal Cognitive Assessment), during prescreening period). * Peri-operative delirium persisting after day 5 of post-operative period. * Inability to provide informed consent * Presence of severe or uncontrolled neurodegenerative disease like Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis * Presence of an underlying muscle disease other than age-associated muscle waste or disuse atrophy. * History of stroke with residual hemiplegia * Diagnosis of a severe medical or psychiatric condition making the participant unlikely to understand or comply with study protocol. * Diagnosis of malignancy done in the 18 months prior the baseline visit. * Severe renal failure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gerontopôle - CHU La Grave Casselardit - Serv. de Médecine Interne & de Gérontologie Clinique - 170 av de Casselardit - TSA 40031

    Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.